Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion type Assertion NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_head.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion description "[A combined prognostic score of tumour budding and CD8(+), FoxP3(+) and CD68(+) distinctly identified patients with low-, moderate- or high-risk colorectal cancers with 5-year survival rates of 75.2% [confidence interval 95% (CI): 66-83], 56.3% (95% CI: 43-68) and 25.2% (95% CI: 14-38), respectively, in MMR-proficient and -deficient cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_provenance.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion evidence source_evidence_literature NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_provenance.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion SIO_000772 22034888 NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_provenance.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion wasDerivedFrom befree-20150227 NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_provenance.
- NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_assertion wasGeneratedBy ECO_0000203 NP899870.RAONDa-nQQEbENaFk0ekrjBCC2cDffjMQol5dbGQDLmlI130_provenance.